Zimmer Biomet Holdings Shares Slip 0.64% on Mixed Trading Day
May 27, 2023
Trending News ☀️
Thursday was an overall mixed trading day in the market, and the stock of Zimmer Biomet ($NYSE:ZBH) Holdings Inc. had a slight decrease of 0.64%, closing at $127.80. Zimmer Biomet Holdings Inc. is a global leader in musculoskeletal healthcare, developing, manufacturing, and marketing products and services that help diagnose, treat, and prevent musculoskeletal disorders. They are dedicated to providing innovative products and services to healthcare professionals around the world, with a focus on enhancing patient care and quality of life. Their commitment to clinical advancement has led to breakthroughs in orthopedic, spine, and trauma technologies, helping people regain mobility and get back to their daily lives.
Analysis
GoodWhale has analyzed ZIMMER BIOMET‘s financials and found that it is classified as a ‘cow’ based on its Star Chart, meaning it has a track record of paying out consistent and sustainable dividends. This type of company may be especially attractive to dividend investors looking for a steady stream of income. ZIMMER BIOMET stands out in terms of dividends and profitability, but is weaker in terms of growth and assets. That said, its high health score of 8/10 with regard to cashflows and debt suggests that it is capable of sustaining future operations in times of crisis. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Zimmer Biomet. More…
| Total Revenues | Net Income | Net Margin |
| 7.11k | 449.7 | 11.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Zimmer Biomet. More…
| Operations | Investing | Financing |
| 1.36k | -590.3 | -860 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Zimmer Biomet. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 21.24k | 9.09k | 57.29 |
Key Ratios Snapshot
Some of the financial key ratios for Zimmer Biomet are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -3.0% | 5.8% | 10.7% |
| FCF Margin | ROE | ROA |
| 16.3% | 4.0% | 2.2% |
Peers
The company operates in two segments, Reconstructive and Dental. It offers knee, hip, shoulder, elbow, hand and wrist, foot and ankle, and biologics products. The company also provides dental prosthetics, including dental implants and CAD/CAM systems; and digital equipment for dentists and laboratories. Zimmer Biomet has a market cap of $24.4 billion and is headquartered in Warsaw, Indiana.
– Alcon Inc ($LTS:0A0D)
Alcon Inc is a global medical company that specializes in eye care products and services. The company’s market cap as of 2022 is 30.09B, and its return on equity is 1.87%. Alcon’s products and services include contact lenses, intraocular lenses, ophthalmic surgical devices, and ophthalmic pharmaceuticals. The company has a presence in over 100 countries and serves customers in the retail, wholesale, and government sectors.
– Sonova Holding AG ($LTS:0QPY)
Sonova Holding AG is a Swiss manufacturer of hearing aids. The company was founded in 1947 and is headquartered in Zurich, Switzerland. As of 2020, Sonova Holding AG had a market cap of 15.37 billion Swiss francs and a return on equity of 18.9%. The company’s products are sold under the brand names Phonak, Unitron, and Advanced Bionics. Sonova Holding AG’s products are available in more than 100 countries.
– Tandem Diabetes Care Inc ($NASDAQ:TNDM)
Tandem Diabetes Care Inc is a medical device company that develops, manufactures and sells insulin pumps for people with diabetes. The company has a market cap of $2.56 billion and a return on equity of -8.79%. Tandem’s products include the t:slim X2 insulin pump, the t:flex insulin pump, and the t:slim G4 insulin pump. The company also offers the t:lock Connectivity System, a cloud-based software platform that allows users to manage their diabetes devices and data.
Summary
Zimmer Biomet Holdings Inc. shares experienced a slight decrease of 0.64% to $127.80 on Thursday. This uneven trading session further demonstrates the unpredictability of investing in the stock market. Analysts suggest that investors should carefully consider potential risks in the company by keeping up to date with their financials and news releases before deciding on any investment. Additionally, it is also paramount to diversify investments to reduce volatility and take advantage of the potential for positive returns.
Related Posts
Recent Posts
